Inventiva (IVA) Receivables (2018 - 2025)
Inventiva (IVA) posted quarterly Receivables of $2.5 million for Q4 2025, up 292.86% year-over-year from $627265.5 in Q4 2024, and down 99.98% quarter-over-quarter from $12.2 billion in Q2 2025.
Analysis
Inventiva (IVA) Receivables (2018 - 2025) Analysis & Trends
Inventiva's Receivables history runs 8 years deep, the most recent figure standing at $2.5 million for Q4 2025.
- In Q4 2025, Receivables rose 292.86% year-over-year to $2.5 million; the TTM figure through Dec 2025 stood at $2.5 million (up 292.86% YoY), while the FY2025 annual figure was $2.5 million, up 292.86% from the prior year.
- Receivables for Q4 2025 stood at $2.5 million, down from $12.2 billion in the prior quarter.
- The five-year high for Receivables was $12.2 billion in Q2 2025, with the low at $8429.9 in Q2 2021.
- The 5-year median for Receivables is $2.5 million (2025), against an average of $1.1 billion.
- The sharpest annual moves came in 2021 and 2025: Receivables slumped 99.53% in 2021, then soared 178786.64% in 2025.
- Inventiva's Receivables stood at $4.9 million in 2021, then slumped by 96.64% to $165280.1 in 2022, then surged by 2661.46% to $4.6 million in 2023, then slumped by 86.26% to $627265.5 in 2024, then jumped by 292.86% to $2.5 million in 2025.
- Business Quant data shows IVA's Receivables at $2.5 million in Q4 2025, $12.2 billion in Q2 2025, and $627265.5 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 160.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.06 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 912.74 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 215.33 Mn |
| 10 | Inventiva | 893.85 Mn | 893.85 Mn | - | 2.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 2.35 Mn |
| Jun 30, 2025 | 12.30 Mn |
| Dec 31, 2024 | 627,265.50 |
| Jun 30, 2024 | 3.27 Mn |
| Dec 31, 2023 | 4.56 Mn |
| Jun 30, 2023 | 3.97 Mn |
| Dec 31, 2022 | 165,280.07 |
| Jun 30, 2022 | 349,994.59 |
| Dec 31, 2021 | 4.58 Mn |
| Jun 30, 2021 | 8,429.90 |
| Mar 31, 2021 | 1.55 Mn |
| Dec 31, 2020 | 2.26 Mn |
| Jun 30, 2020 | 1.79 Mn |
| Dec 31, 2019 | 1.00 Mn |
| Dec 31, 2018 | 6,848.38 |